Pillai Segaran P, Fruetel Julia A, Anderson Kevin, Levinson Rebecca, Hernandez Patricia, Heimer Brandon, Morse Stephen A
Office of the Commissioner, Food and Drug Administration, U.S. Department of Health and Human Services, Silver Spring, MD, United States.
Sandia National Laboratory, U.S. Department of Energy, Livermore, CA, United States.
Front Bioeng Biotechnol. 2022 Jun 3;10:756586. doi: 10.3389/fbioe.2022.756586. eCollection 2022.
The Centers for Disease Control and Prevention (CDC) Select Agent Program establishes a list of biological agents and toxins that potentially threaten public health and safety, the procedures governing the possession, utilization, and transfer of those agents, and training requirements for entities working with them. Every 2 years the Program reviews the select agent list, utilizing subject matter expert (SME) assessments to rank the agents. In this study, we explore the applicability of multi-criteria decision analysis (MCDA) techniques and logic tree analysis to support the CDC Select Agent Program biennial review process, applying the approach broadly to include non-select agents to evaluate its generality. We conducted a literature search for over 70 pathogens against 15 criteria for assessing public health and bioterrorism risk and documented the findings for archiving. The most prominent data gaps were found for aerosol stability and human infectious dose by inhalation and ingestion routes. Technical review of published data and associated scoring recommendations by pathogen-specific SMEs was found to be critical for accuracy, particularly for pathogens with very few known cases, or where proxy data (e.g., from animal models or similar organisms) were used to address data gaps. Analysis of results obtained from a two-dimensional plot of weighted scores for difficulty of attack (i.e., exposure and production criteria) vs. consequences of an attack (i.e., consequence and mitigation criteria) provided greater fidelity for understanding agent placement compared to a 1-to-n ranking and was used to define a region in the upper right-hand quadrant for identifying pathogens for consideration as select agents. A sensitivity analysis varied the numerical weights attributed to various properties of the pathogens to identify potential quantitative (x and y) thresholds for classifying select agents. The results indicate while there is some clustering of agent scores to suggest thresholds, there are still pathogens that score close to any threshold, suggesting that thresholding "by eye" may not be sufficient. The sensitivity analysis indicates quantitative thresholds are plausible, and there is good agreement of the analytical results with select agent designations. A second analytical approach that applied the data using a logic tree format to rule out pathogens for consideration as select agents arrived at similar conclusions.
美国疾病控制与预防中心(CDC)的特定病原体计划制定了一份可能威胁公众健康与安全的生物制剂和毒素清单,以及有关这些制剂的持有、使用和转移的管理程序,还有针对与之打交道的实体的培训要求。该计划每两年对特定病原体清单进行一次审查,利用主题专家(SME)评估对这些制剂进行排名。在本研究中,我们探讨了多标准决策分析(MCDA)技术和逻辑树分析在支持CDC特定病原体计划两年期审查过程中的适用性,广泛应用该方法以纳入非特定病原体,从而评估其通用性。我们针对70多种病原体,依据15项评估公共卫生和生物恐怖主义风险的标准进行了文献检索,并记录研究结果以供存档。在气溶胶稳定性以及通过吸入和摄入途径的人类感染剂量方面,发现了最显著的数据空白。发现由特定病原体的主题专家对已发表数据及相关评分建议进行技术审查对于准确性至关重要,特别是对于已知病例极少的病原体,或者在使用替代数据(例如来自动物模型或类似生物体的数据)来填补数据空白的情况。与1对n排名相比,对攻击难度(即暴露和生产标准)与攻击后果(即后果和缓解标准)的加权分数进行二维绘图分析得到的结果,在理解制剂分类方面提供了更高的保真度,并用于在右上象限定义一个区域,以识别可作为特定病原体加以考虑的病原体。敏感性分析改变了赋予病原体各种属性的数值权重,以确定用于分类特定病原体的潜在定量(x和y)阈值。结果表明,虽然制剂分数存在一些聚类现象暗示了阈值,但仍有一些病原体的分数接近任何阈值,这表明仅凭“肉眼”设定阈值可能并不足够。敏感性分析表明定量阈值是合理的,并且分析结果与特定病原体的指定有很好的一致性。另一种分析方法是使用逻辑树格式应用数据,以排除可作为特定病原体加以考虑的病原体,得出了类似的结论。